Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

S 2242

Known as: S-2242, S2242 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
ABSTRACT The absence of any formally licensed antiadenovirus drugs and the increasing incidence of life-threatening adenovirus… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Review
2004
Review
2004
Several nucleoside and nucleotide analogues have been identified as potent antiviral agents with convincing activity against… Expand
Review
2001
Review
2001
A series of antiviral compounds were examined for their activity against human herpesvirus type 6 (HHV‐6), type 7 (HHV‐7) and… Expand
2001
2001
ABSTRACT We have previously shown that the N-7 substituted acyclic nucleoside analog 2-amino-7-[1,3-dihydroxy-2-propoxy)methyl… Expand
  • figure 2
  • table 1
  • table 2
Review
2001
Review
2001
  • E. De Clercq
  • Clinical Microbiology Reviews
  • 2001
  • Corpus ID: 16633143
SUMMARY Poxviruses continue to pose a major threat to human health. Monkeypox is endemic in central Africa, and the… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
1999
1999
Human herpesvirus virus type 7 (HHV-7) is a T-lymphotropic herpesvirus which uses the CD4 receptor as main receptor to infect its… Expand
Highly Cited
1997
Highly Cited
1997
We studied the susceptibility of human herpesvirus 8 (HHV-8) to a number of antiherpesvirus agents. The acyclic nucleoside… Expand
Highly Cited
1997
Highly Cited
1997
We used recombinant vaccinia viruses (rVV) containing the UL97 open reading frame (ORF) of the human cytomegalovirus (HCMV) to… Expand
Highly Cited
1995
Highly Cited
1995
Human herpesvirus 6 (HHV-6) was examined in vitro for its sensitivity to a broad range of nucleoside analogues, including… Expand
1994
1994
2-Amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine (compound S2242) represents the first antivirally active nucleoside analog with… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3